Bisacodyl/magnesium citrate

MCL-1/BCL-2-IN-2 (Compound Nap-1) is a potent and selective Mcl-1 and Bcl-2 dual inhibitor with IC 50 s of 4.45 and 3.18 μM, respectively.Appearance:SolidIC50&amp: Target:Mcl-1 4.45 μM (IC 50 ) Bcl-2 3.18 μM (IC 50 )Biological

MCL-1/BCL-2-IN-2 (Compound 6) is a potent and selective Mcl-1 and Bcl-2 dual inhibitor.Form:Solid.

MCL-1/BCL-2-IN-2 (Compound 6) is a potent and selective Mcl-1 and Bcl-2 dual inhibitor.Form:Solid.

MCL-1/BCL-2-IN-2 (Compound 6) is a potent and selective Mcl-1 and Bcl-2 dual inhibitor.Form:Solid.

MCL-1/BCL-2-IN-2 (Compound 6) is a potent and selective Mcl-1 and Bcl-2 dual inhibitor.Form:Solid.

Intestinal Forceps, 9 Straight";MPN=V916-160"

General description Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely

General description Guanylyl cyclase C (GCC, or GUCY2C: MIM 601330) produces cGMP following the binding of either endogenous ligands or heat-stable enterotoxins secreted by E. coli and other enteric bacteria.

General description Guanylyl cyclase C (GCC, or GUCY2C: MIM 601330) produces cGMP following the binding of either endogenous ligands or heat-stable enterotoxins secreted by E. coli and other enteric bacteria.

Immunogen The epitope recognized by PLA0309 maps to a region between residue 1650 and the C-terminus (residue 1708) of human Rapamycin-Insensitive Companion of mTOR using the numbering given in TrEMBL entry Q6R327 (GeneID 253260). Physical form

Can be used for complete or supplemental nutrition support. An ideal short- or long-term tube feeding for patients with very high caloric requirements and/or a severe fluid restriction.

Ready-to-use for complete or supplemental tube feeding. It is specifically formulated for easy digestion and absorption for patients with impaired gastrointestinal function and normal or increased caloric requirements.